These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31421087)

  • 1. Chronic memantine decreases nicotine self-administration in rats.
    Levin ED; Wells C; Yao L; Guo W; Nangia A; Howard S; Pippen E; Hawkey AB; Rose JE; Rezvani AH
    Eur J Pharmacol; 2019 Oct; 861():172592. PubMed ID: 31421087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic glutamate NMDA antagonist treatment attenuates dopamine D
    Natarajan S; Abass G; Kim L; Wells C; Rezvani AH; Levin ED
    Pharmacol Biochem Behav; 2024 Jan; 234():173678. PubMed ID: 37979731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D
    DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED
    Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs.
    Cousins V; Rose JE; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():200-5. PubMed ID: 24953434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic interactive treatments of serotonin 5HT
    Willette BKA; Nangia A; Howard S; DiPalma D; McMillan C; Tharwani S; Evans J; Wells C; Slade S; Hall BJ; Rezvani AH; Levin ED
    Pharmacol Biochem Behav; 2019 Nov; 186():172766. PubMed ID: 31470021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
    Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE
    Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys.
    Justinova Z; Panlilio LV; Secci ME; Redhi GH; Schindler CW; Cross AJ; Mrzljak L; Medd A; Shaham Y; Goldberg SR
    Biol Psychiatry; 2015 Oct; 78(7):452-62. PubMed ID: 25802079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
    Zakharova ES; Danysz W; Bespalov AY
    Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.
    Li X; D'Souza MS; Niño AM; Doherty J; Cross A; Markou A
    Psychopharmacology (Berl); 2016 May; 233(10):1801-14. PubMed ID: 26873083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.
    Rezvani AH; Slade S; Wells C; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2017 Sep; 234(17):2517-2523. PubMed ID: 28555315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.
    Briggs SA; Hall BJ; Wells C; Slade S; Jaskowski P; Morrison M; Rezvani AH; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2016 Mar; 142():1-7. PubMed ID: 26704812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats.
    Rezvani AH; Tizabi Y; Slade S; Getachew B; Levin ED
    Neurosci Lett; 2018 Mar; 668():98-102. PubMed ID: 29339170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.
    Levin ED; Slade S; Wells C; Pruitt M; Cousins V; Cauley M; Petro A; Hampton D; Rose J
    Eur J Pharmacol; 2011 Jan; 650(1):256-60. PubMed ID: 20951696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice.
    Blokhina EA; Kashkin VA; Zvartau EE; Danysz W; Bespalov AY
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):219-25. PubMed ID: 15695068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions.
    Levin ED; Wells C; Slade S; Lee M; McKinney AA; Rose JE; Rezvani AH
    Nicotine Tob Res; 2020 Feb; 22(2):232-237. PubMed ID: 31187118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.
    Levin ED; Slade S; Wells C; Petro A; Rose JE
    Pharmacol Biochem Behav; 2011 Apr; 98(2):210-4. PubMed ID: 21192967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats.
    Hall BJ; Slade S; Allenby C; Kutlu MG; Levin ED
    Neuropharmacology; 2015 Dec; 99():689-95. PubMed ID: 25797492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-quit nicotine decreases nicotine self-administration and attenuates cue- and drug-induced reinstatement.
    Clemens KJ; Stuart A; Ferguson SG
    J Psychopharmacol; 2019 Mar; 33(3):364-371. PubMed ID: 30698057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.